Low-dose radiotherapy effects the progression of anti-tumor response

Bibliographic Details
Title: Low-dose radiotherapy effects the progression of anti-tumor response
Authors: Lei Gao, Anqi Zhang
Source: Translational Oncology, Vol 35, Iss , Pp 101710- (2023)
Publisher Information: Elsevier, 2023.
Publication Year: 2023
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Low-dose radiotherapy, Biological effect, Microenvironment, Immune system, Tumor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: The history of low-dose radiotherapy (LDRT or LDR) as a treatment modality for malignant tumors dates back to the 1920s. Even with the minimal total dose administered during treatment, LDRT can result in long-lasting remission. Autocrine and paracrine signaling are widely recognized for fostering the growth and development of tumor cells. LDRT exerts systemic anti-tumor effects through various mechanisms, such as enhancing the activity of immune cells and cytokines, shifting the immune response towards an anti-tumor phenotype, influencing gene expression, and blocking crucial immunosuppressive pathways. Additionally, LDRT has been demonstrated to enhance the infiltration of activated T cells and initiate a series of inflammatory processes while modulating the tumor microenvironment. In this context, the objective of receiving radiation is not to directly kill tumor cells but to reprogram the immune system. Enhancing anti-tumor immunity may be a critical mechanism by which LDRT plays a role in cancer suppression. Therefore, this review primarily focuses on the clinical and preclinical efficacy of LDRT in combination with other anti-cancer strategies, such as the interaction between LDRT and the tumor microenvironment, and the remodeling of the immune system.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1936-5233
Relation: http://www.sciencedirect.com/science/article/pii/S1936523323000967; https://doaj.org/toc/1936-5233
DOI: 10.1016/j.tranon.2023.101710
Access URL: https://doaj.org/article/96773610142c4194a9d46c6716852f38
Accession Number: edsdoj.96773610142c4194a9d46c6716852f38
Database: Directory of Open Access Journals
More Details
ISSN:19365233
DOI:10.1016/j.tranon.2023.101710
Published in:Translational Oncology
Language:English